As DNMT1 functions during DNA replication to copy methylation patterns from parental strands to daughter strands, DNMT1 inhibitors are effective against rapidly cycling cells of hematological malignancy, but have limited effectiveness against solid tumors, which generally replicate more slowly [28]. The gene discussed is DNMT1; the disease is hematologic disorder.